COMP <GO>
PLUS vs SCSC // EV/EBITDA & P/E VALUATION
ePlus inc. (NASDAQ) VS. ScanSource Inc. (NASDAQ) • 15-METRIC TALLY: PLUS 10
— SCSC 3
▲ EV/EBITDA & P/E VALUATION LEADER: PLUS
LAST: $95.49 (+0.35%) • MKT CAP: $2.49B
valuation
12.7x
LAST: $58.98 (-0.77%) • MKT CAP: $1.20B
valuation
14.3x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (PLUS VS. SCSC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | PLUS | SCSC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.20% | 13.40% | +11.80 | PLUS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.80% | 7.30% | +10.50 | PLUS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 12.7x | 14.3x | -1.60 | PLUS | /valuation <GO> |
| Free Cash Flow Yield | -4.84% | 9.35% | -14.19 | SCSC | /fcf-yield <GO> |
| Operating Margin | 6.80% | 2.80% | +4.00 | PLUS | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 2.40% | +3.00 | PLUS | /net-margins <GO> |
| Revenue Growth (YoY) | 22.10% | -6.70% | +28.80 | PLUS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.79% | 0.00% | +0.79 | PLUS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.81 | 4.04 | +0.77 | PLUS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 6/9 | -1.00 | SCSC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.6 | 41.7 | +5.82 | PLUS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.8x | 15.6x | +0.20 | SCSC | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.49B | $1.20B | $1.29B | PLUS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | PLUS REV | SCSC REV | PLUS GROSS % | SCSC GROSS % | PLUS FCF | SCSC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.44B | $3.04B | 25.2% | 13.4% | -$120.7M | $112.3M |
| FY 2024 | $2.00B | $3.26B | 25.6% | 12.2% | $296.9M | $371.6M |
| FY 2023 | $2.18B | $3.79B | — | — | $248.4M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
PLUS // BETA —
SCSC // BETA —